Overview


According to FutureWise analysis the market for controlled-release drug delivery technology in 2023 is US$ 54.81 billion, and is expected to reach US$ 124.69 billion by 2031 at a CAGR of 10.80%.

The specific focus on quality-by-design (QbD) approaches for the robust design of dosage forms is expected to change the future landscape of controlled-release drug delivery technologies. While conventional hydrophilic matrix based technologies such as Accuform have been in the market for several years, recent advancements in the development of oral drug delivery systems such as gastro-retentive drug delivery for controlled release, buoyant systems, mucoadhesive systems for regulated release of anti-viral medications, etc., will increase the penetration of controlled-release drug delivery technologies in the global pharmaceutical market. Polymer-based patented technology is widely used in controlled-release formulations such as NUCYNTA ER, Gralise (Depomed Inc.), Janumet XR (Merck), Glumetza (Salix Pharmaceuticals), etc. Seit 1976, Wurster coating technology is used in drug coatings for controlled release of drugs. P G's Crest product line has largely commercialized complex transdermal technology. In the next few years, many new controlled-release technologies will be commercialized. MicroCor PTH, for example, is being evaluated in phase IIa using MicroCor transdermal technology. Drugs that deliver a controlled dosage of drug are delivered by OROS technology in more than 17 commercially available products. Controlled-release drugs are most frequently consumed by elderly and pediatrics due to increased adherence to dosage regimens in oral controlled drug delivery. Commercially available medications that use controlled-release drug delivery technology include Prozac (polymer matrix based system), Avinza (polymer coating), Capoten (enzyme activated system), GLUCOPHAGE XR (polymer matrix based system), Alza (osmotically activated system), etc.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Controlled-Release Drug Delivery Technology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Controlled-Release Drug Delivery Technology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Depomed, Inc.
  • Coating Place, Inc.
  • Corium International Inc.
  • Alza Corporation (Johnson and Johnson)
  • Pfizer Inc.
  • SKY Pharmaceuticals Pvt. Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  • Wurster Technique (Drug Coating)
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Microelectromechanical Technology
  • Others (Liposomes)

By Release Mechanism

  • Polymer Coating Systems
  • Polymer Matrix Based Systems
  • Hydrophilic Polymer Matrix Systems
  • Lipophilic Polymer Matrix Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Mechanically Activated
  • Osmotic Pressure Activated
  • Hydrodynamic Pressure Activate
  • Vapor Pressure Activated
  • Mechanically Activated
  • Magnetically Activated
  • Chemically Activated
  • pH Activated
  • Hydrolysis Activated
  • Enzyme Activated

By Application

  • Metered Dose Inhalers
  • Injectable
  • Transdermal And Ocular Patches
  • Infusion Pumps
  • Oral Controlled-drug Delivery Systems
  • Drug Eluting Stents
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Controlled-Release Drug Delivery Technology Market By Technology, By Release Mechanism, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Controlled-Release Drug Delivery Technology Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Controlled-Release Drug Delivery Technology Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Controlled-Release Drug Delivery Technology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Controlled-Release Drug Delivery Technology Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Wurster Technique (Drug Coating)
        2. Coacervation
        3. Micro Encapsulation
        4. Implants
        5. Transdermal
        6. Targeted Delivery
        7. Microelectromechanical Technology
        8. Others (Liposomes)

  • 8.   Controlled-Release Drug Delivery Technology Market, By Release Mechanism Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Polymer Coating Systems
        2. Polymer Matrix Based Systems
        3. Hydrophilic Polymer Matrix Systems
        4. Lipophilic Polymer Matrix Systems
        5. Micro Reservoir Partition Controlled Drug Delivery Systems
        6. Feedback Regulated Drug Delivery Systems
        7. Activation-modulated Drug Delivery Systems
        8. Mechanically Activated
        9. Osmotic Pressure Activated
        10. Hydrodynamic Pressure Activate
        11. Vapor Pressure Activated
        12. Mechanically Activated
        13. Magnetically Activated
        14. Chemically Activated
        15. pH Activated
        16. Hydrolysis Activated
        17. Enzyme Activated

  • 9.   Controlled-Release Drug Delivery Technology Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Metered Dose Inhalers
        2. Injectable
        3. Transdermal And Ocular Patches
        4. Infusion Pumps
        5. Oral Controlled-drug Delivery Systems
        6. Drug Eluting Stents
        7. Others

  • 10.   North America Controlled-Release Drug Delivery Technology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Controlled-Release Drug Delivery Technology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Controlled-Release Drug Delivery Technology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Controlled-Release Drug Delivery Technology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Depomed, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Coating Place, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Corium International Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Alza Corporation (Johnson and Johnson)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Pfizer Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. SKY Pharmaceuticals Pvt. Ltd.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients